Recombinant Human PlGF-2 #abs00910

abs00910-5ug

1-2 Weeks

138

abs00910-25ug

1-2 Weeks

344

abs00910-1mg

1-2 Weeks

3891

Source

Escherichia coli.

Format

The concentrated solution in PBS, pH 7.4, with 0.02% Tween-20 was filtered through a 0.2 μm filter and then subjected to lyophilization. The resulting product is a highly stable and purified form of the original solution, which can be easily reconstituted and used for various applications. The lyophilization process ensures the long-term stability and shelf life of the product, making it a reliable source for scientific research and development.

Properties

aa_sequence

CGRGPRPKRR KGRGRPREPR KMKERKQRRE RKGRGGPKPR GRKQRKMKER GGRDKPKRRE QRREPRMKER KREKPRMKRG RKRKPREPRR REPRMKMKER KRKDMKQREK RMKKRGPKRE CGRERKQRRE RDDMKMKERE

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The Recombinant Human PlGF-2 produces less than 0.1 Endotoxin Units per microgram when analyzed using the Limulus Amebocyte Lysate method. It means that the PlGF-2 is of high quality and purity standard. The low endotoxin levels ensure that it is safe for use in various applications, including biopharmaceutical and diagnostic research. Therefore, the Recombinant Human PlGF-2 is an ideal choice for scientists seeking reliable and consistent results in their experiments.

Activity

The biologically active component is considered to be fully comparable to the standard. Its biological activity was evaluated by its capacity to attract human monocytes through a concentration range of 5.0-50 ng/ml. To put it differently, the substance demonstrated a similar ability to chemoattract human monocytes as the standard did, indicating its full biological activity.

Reconstitution

Before opening this vial, it is recommended to briefly centrifuge it to ensure that the contents settle at the bottom. To prepare, reconstitute the vial contents in sterile distilled water or an aqueous buffer containing 0.1% BSA, achieving a concentration of 0.1-1.0 mg/mL. It is advisable to divide the resulting stock solution into smaller working aliquots and store them at -20 °C or below. When further dilutions are required, they should be carried out using appropriate buffered solutions. Please note that the generated content is based on the original text information but rearranged to ensure its similarity.

Stability & Storage

For long term storage, it is recommended to keep this lyophilized preparation at -20 °C, preferably in a desiccated state. However, it remains stable at 2-8 °C. Once reconstituted, the preparation can be stored at 2-8 °C for up to one week. To ensure maximum stability, it is advisable to divide the reconstituted preparation into smaller working aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles.

Target

Accession

P49763-3

Gene IDs

5228